- Home
- VTYX vs SKIN Comparison
VTYX vs SKIN Comparison
Compare VTYX & SKIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- SKIN
- Stock Information
- Founded
- VTYX 2018
- SKIN 1997
- Country
- VTYX United States
- SKIN United States
- Employees
- VTYX N/A
- SKIN N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- SKIN Package Goods/Cosmetics
- Sector
- VTYX Health Care
- SKIN Consumer Discretionary
- Exchange
- VTYX Nasdaq
- SKIN Nasdaq
- Market Cap
- VTYX 154.9M
- SKIN 164.1M
- IPO Year
- VTYX 2021
- SKIN N/A
- Fundamental
- Price
- VTYX $1.07
- SKIN $1.23
- Analyst Decision
- VTYX Buy
- SKIN Hold
- Analyst Count
- VTYX 4
- SKIN 5
- Target Price
- VTYX $11.33
- SKIN $2.50
- AVG Volume (30 Days)
- VTYX 731.3K
- SKIN 648.4K
- Earning Date
- VTYX 05-08-2025
- SKIN 03-12-2025
- Dividend Yield
- VTYX N/A
- SKIN N/A
- EPS Growth
- VTYX N/A
- SKIN N/A
- EPS
- VTYX N/A
- SKIN N/A
- Revenue
- VTYX N/A
- SKIN $334,294,000.00
- Revenue This Year
- VTYX N/A
- SKIN $1.93
- Revenue Next Year
- VTYX N/A
- SKIN $12.41
- P/E Ratio
- VTYX N/A
- SKIN N/A
- Revenue Growth
- VTYX N/A
- SKIN N/A
- 52 Week Low
- VTYX $1.07
- SKIN $0.91
- 52 Week High
- VTYX $5.66
- SKIN $4.23
- Technical
- Relative Strength Index (RSI)
- VTYX 23.19
- SKIN 38.14
- Support Level
- VTYX $1.28
- SKIN $1.25
- Resistance Level
- VTYX $1.37
- SKIN $1.39
- Average True Range (ATR)
- VTYX 0.08
- SKIN 0.11
- MACD
- VTYX -0.01
- SKIN 0.00
- Stochastic Oscillator
- VTYX 0.00
- SKIN 2.86
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About SKIN The Beauty Health Company
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.